Spinal cord injury patients get first shot at novel cell delivery device
Disease control
Recruiting now
This early-stage trial tests a new device designed to deliver OPC1 cells directly into the spinal cord of people with traumatic spinal cord injuries. The study will enroll 10 participants with either recent or chronic injuries. The main goal is to see if the device and injection …
Phase: PHASE1 • Sponsor: Lineage Cell Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC